To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended?

  title={To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended?},
  author={Gigi van de Loo-Neus and Nanda N. J. Rommelse and Jan K. Buitelaar},
  journal={European Neuropsychopharmacology},

Tables from this paper

Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms

Results from the COMPAS trial demonstrate an improvement of ADHD symptoms over 1.5 years in adults with ADHD after 1 year of treatment with methylphenidate plus either GPT or CM.

Attention deficit hyperactivity disorder in adults

Examination of available literature regarding attention deficit hyperactivity disorder in adults found psychological therapy may be beneficial in adults who continue to experience clinically significant symptoms while receiving pharmacotherapy, and these therapies are generally well tolerated.

Effect of Continuing and Discontinuing Medications on Quality of Life After Symptomatic Remission in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis.

Discontinuing medications was associated with a small but statistically significant decrease in quality of life among children and adolescents with ADHD but not in adults with ADHD.

Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan

It is suggested that IR–MPH is the most frequently prescribed drug for ADHD treatment in Taiwan and an older age at first prescription and a higher daily dose of prescription were significant predictors of early discontinuation of ADHD medication.

Does Long-Term Medication Use Improve the Academic Outcomes of Youth with Attention-Deficit/Hyperactivity Disorder?

It is demonstrated that long-term medication use is associated with improvements in standardized achievement scores, however, the magnitude of these improvements is small and the clinical or educational significance is questionable, which highlights methodological considerations in providing directions for future research.

Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial

This study will inform mental health care professionals and health insurance companies about the clinical and cost effectiveness of mindfulness training for children and adolescents with ADHD and their parents compared to the effectiveness of methylphenidate.

Effect of Treatment Modality on Long-Term Outcomes in Attention-Deficit/Hyperactivity Disorder: A Systematic Review

The combination of pharmacological and non-pharmacological treatment was most consistently associated with improved long-term outcomes and large effect sizes.

First-Time Users of ADHD Medication Among Children and Adolescents in Germany: An Evaluation of Adherence to Prescribing Guidelines Based on Claims Data

The results suggest the need for improvement in rational prescribing, especially with regard to diagnostic requirements, in first-time users of ADHD medication among children and adolescents in Germany.

Slow cortical potential neurofeedback and self-management training in outpatient care for children with ADHD: study protocol and first preliminary results of a randomized controlled trial

First preliminary results show positive effects, and this is the first randomized controlled trial to test the effectiveness of a NF protocol in a high frequent outpatient care setting that does not exclude children on or with changes in medication.



Using Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit/Hyperactivity Disorder in Youths.

  • S. Faraone
  • Psychology, Medicine
    P & T : a peer-reviewed journal for formulary management
  • 2009
Although nearly all of the ADHD medications had significant effects, there was substantial variability and when translated into the costs of treating large numbers of patients, these effect sizes have implications for formulary medication choices.

Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study.

In patients who responded favorably to 12 weeks of initial treatment, atomoxetine was superior to placebo in maintaining response for the ensuing 9 months, and this result supports the value of maintenance treatment with atomxetine in patients with ADHD who respond to initial treatment.

Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial.

The results of this long-term, placebo-controlled study of the central stimulant amphetamine in the treatment of ADHD indicate that there are remaining positive effects of the drug 15 months after starting treatment.

A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.

Although both stimulant and nonstimulant medications are effective for treating ADHD in adults, stimulant medications show greater efficacy for the short durations of treatment characteristic of placebo-controlled studies.

Childhood hyperactivity and psychostimulants: a review of extended treatment studies.

Evidence from the more definitive randomized controlled trials indicates that stimulants are more effective in ameliorating the core behavioral symptoms of ADHD than placebos, nonpharmacological therapies, or no treatment-at least in 3-7-month trials.

Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.

Long-term treatment with methylphenidate seems to be safe and effective for the management of ADHD behaviors in many (but not necessarily all) children with mild to moderate tic disorder.

A Randomized, Double-Blind Study of Continuation Treatment for Attention-Deficit/Hyperactivity Disorder After 1 Year

Long-Term Stimulant Medication Treatment of Attention-Deficit/Hyperactivity Disorder: Results from a Population-Based Study

It is demonstrated that the effectiveness of stimulant medication treatment of ADHD provided throughout childhood is comparable to the efficacy of Stimulant treatment demonstrated in clinical trials.

Treatment of ADHD in children with tics: a randomized controlled trial.

Methylphenidate and clonidine (particularly in combination) are effective for ADHD in children with comorbid tics, and prior recommendations to avoid methylphenidate in these children because of concerns of worsening tics are unsupported by this trial.

Treatment of ADHD in children with tics: A randomized controlled trial

  • S. Deputy
  • Medicine, Psychology
    Clinical pediatrics
  • 2002
Methylphenidate and clonidine (particularly in combination) are effective for ADHD in children with comorbid tics, and prior recommendations to avoid methylphenidate in these children because of concerns of worsening tics are unsupported by this trial.